Patents Assigned to Respiratory Management Technology
  • Patent number: 8353845
    Abstract: An apparatus for measuring lung ventilation, comprising: a pressure device to measure volume of air flow; an aerosol-generating device that provides aerosol particles to be released at a determined point in a breathing cycle; a mouthpiece with a detector that measures the concentration of aerosol particles for a given volume during the breathing cycle; and a computing device configured to provide lung ventilation data as a function of time constants.
    Type: Grant
    Filed: June 16, 2011
    Date of Patent: January 15, 2013
    Assignee: Respiratory Management Technology
    Inventors: Michael McCawley, Gary Gasner, Ian Christie, Tal Gottesman, James Dalton
  • Publication number: 20110247611
    Abstract: An apparatus for measuring lung ventilation, comprising: a pressure device to measure volume of air flow; an aerosol-generating device that provides aerosol particles to be released at a determined point in a breathing cycle; a mouthpiece with a detector that measures the concentration of aerosol particles for a given volume during the breathing cycle; and a computing device configured to provide lung ventilation data as a function of time constants.
    Type: Application
    Filed: June 16, 2011
    Publication date: October 13, 2011
    Applicant: Respiratory Management Technology
    Inventors: Michael McCawley, Gary Ganser, Ian Christie, Tal Gottesman, James Dalton
  • Patent number: 7988641
    Abstract: An apparatus for measuring lung ventilation, comprising: a pressure device to measure volume of air flow; an aerosol-generating device that provides aerosol particles to be released at a determined point in a breathing cycle; a mouthpiece with a detector that measures the concentration of aerosol particles for a given volume during the breathing cycle; and a computing device configured to provide lung ventilation data as a function of time constants.
    Type: Grant
    Filed: April 30, 2010
    Date of Patent: August 2, 2011
    Assignee: Respiratory Management Technology
    Inventors: Michael McCawley, Gary Gasner, Ian Christie, Tal Gottesman, James Dalton
  • Patent number: 7880878
    Abstract: The Nebulized Airborne Biohazard Stage Alert (NABSA) is a method utilizing an optical particle counter in conjunction with a fluorometer as triggers to detect and assess potential biohazard threats infused into surrounding air. In the first stage an optical particle counter is constantly passing sampled air in front of an energy source, in turn scattering light. This scattered light is evaluated to establish if the particles are above one micrometer in concentrations, and thus potentially an aerosolized threat. Such detection triggers the secondary stage in which the sample particles are tested for viability via processing through a dye with fluorescent properties affected when bonded with an entity universally found in all biological substances and a UV light source. The detection of concentrations of oversized, viable particles triggers the third stage to compare a sample of the particles to known biowarfare agents to delineate the specific agent species.
    Type: Grant
    Filed: June 14, 2010
    Date of Patent: February 1, 2011
    Assignee: Respiratory Management Technology
    Inventors: Michael McCawley, Simon Goetze, Phillip Green, II, Jeannette Hoy, Bernard McGee
  • Publication number: 20100253944
    Abstract: The Nebulized Airborne Biohazard Stage Alert (NABSA) is a method utilizing an optical particle counter in conjunction with a fluorometer as triggers to detect and assess potential biohazard threats infused into surrounding air. In the first stage an optical particle counter is constantly passing sampled air in front of an energy source, in turn scattering light. This scattered light is evaluated to establish if the particles are above one micrometer in concentrations, and thus potentially an aerosolized threat. Such detection triggers the secondary stage in which the sample particles are tested for viability via processing through a dye with fluorescent properties affected when bonded with an entity universally found in all biological substances and a UV light source. The detection of concentrations of oversized, viable particles triggers the third stage to compare a sample of the particles to known biowarfare agents to delineate the specific agent species.
    Type: Application
    Filed: June 14, 2010
    Publication date: October 7, 2010
    Applicant: Respiratory Management Technology
    Inventors: Michael McCawley, Simon Goetze, Phillip Green, II, Jeannette Hoy, B. J. McGee
  • Publication number: 20100222692
    Abstract: An apparatus for measuring lung ventilation, comprising: a pressure device to measure volume of air flow; an aerosol-generating device that provides aerosol particles to be released at a determined point in a breathing cycle; a mouthpiece with a detector that measures the concentration of aerosol particles for a given volume during the breathing cycle; and a computing device configured to provide lung ventilation data as a function of time constants.
    Type: Application
    Filed: April 30, 2010
    Publication date: September 2, 2010
    Applicant: Respiratory Management Technology
    Inventors: Michael McCawley, Gary Gasner, Ian Christie, Tal Gottesman, James Dalton
  • Patent number: 7738100
    Abstract: The Nebulized Airborne Biohazard Stage Alert (NABSA) is a method utilizing an optical particle counter in conjunction with a fluorometer as triggers to detect and assess potential biohazard threats infused into surrounding air. In the first stage an optical particle counter is constantly passing sampled air in front of an energy source, in turn scattering light. This scattered light is evaluated to establish if the particles are above one micrometer in concentrations, and thus potentially an aerosolized threat. Such detection triggers the secondary stage in which the sample particles are tested for viability via processing through a dye with fluorescent properties affected when bonded with an entity universally found in all biological substances and a UV light source. The detection of concentrations of oversized, viable particles triggers the third stage to compare a sample of the particles to known biowarfare agents to delineate the specific agent species.
    Type: Grant
    Filed: July 21, 2006
    Date of Patent: June 15, 2010
    Assignee: Respiratory Management Technology
    Inventors: Michael McCawley, Simon Goetze, Phillip Green, II, Jeannette Hoy, Bernard McGee
  • Patent number: 7732749
    Abstract: A system for measuring the output of a photodetector is disclosed. An integrating amplifier circuit receives a signal output from the photodetector and is adapted to output an integrating amplifier voltage proportional to the signal output from the photodetector. A reference source is adapted to serve as a voltage source and is adapted to output a reference voltage proportional to background light incident upon the photodetector. A difference amplifier electronically coupled to the integrating amplifier circuit and to the adjustable reference, receiving the integrating amplifier voltage and the reference voltage, respectively. The difference amplifier is adapted to generate an amplified output using the reference voltage subtracted from the integrating amplifier voltage.
    Type: Grant
    Filed: February 28, 2008
    Date of Patent: June 8, 2010
    Assignee: Respiratory Management Technology
    Inventor: Michael McCawley
  • Patent number: 7731666
    Abstract: An apparatus for measuring lung ventilation, comprising: a pressure device to measure volume of air flow; an aerosol-generating device that provides aerosol particles to be released at a determined point in a breathing cycle; a mouthpiece with a detector that measures the concentration of aerosol particles for a given volume during the breathing cycle; and a computing device configured to provide lung ventilation data as a function of time constants.
    Type: Grant
    Filed: June 29, 2007
    Date of Patent: June 8, 2010
    Assignee: Respiratory Management Technology
    Inventors: Michael McCawley, Gary Ganser, Ian Christie, Tal Gottesman, James Dalton
  • Publication number: 20090168051
    Abstract: The Nebulized Airborne Biohazard Stage Alert (NABSA) is a method utilizing an optical particle counter in conjunction with a fluorometer as triggers to detect and assess potential biohazard threats infused into surrounding air. In the first stage an optical particle counter is constantly passing sampled air in front of an energy source, in turn scattering light. This scattered light is evaluated to establish if the particles are above one micrometer in concentrations, and thus potentially an aerosolized threat. Such detection triggers the secondary stage in which the sample particles are tested for viability via processing through a dye with fluorescent properties affected when bonded with an entity universally found in all biological substances and a UV light source. The detection of concentrations of oversized, viable particles triggers the third stage to compare a sample of the particles to known biowarfare agents to delineate the specific agent species.
    Type: Application
    Filed: July 21, 2006
    Publication date: July 2, 2009
    Applicant: Respiratory Management Technology
    Inventors: Michael McCawley, Simon Goetze, Phillip Green, II, Jeannette Hoy, B. J. McGee
  • Publication number: 20080135735
    Abstract: A light scattering photometer signal-enhancement systems includes an adaptive sample and subtract circuit controlled by a computer or microcontroller (MCU). The MCU controls the gain of a programmable-gain amplifier (PGA) cascade that is used to amplify the raw photometer signal. In order to maintain the DC accuracy, the DC offset contained in the raw signal from the photometer is estimated by an algorithmic within the MCU and then subtracted from the raw signal before allowing it to be amplified by the PGA cascade. In addition to DC estimation and adaptive cancellation, the MCU applies a digital filtering scheme to compensate irrelevant frequency bands in the amplified signal and offers user determined averaging functions for additional signal conditioning. Moreover, hardware filters are used to prevent signal aliasing by the analog to digital converters (ADC) and a 60 Hz notch filter suppresses general electrical noise.
    Type: Application
    Filed: July 10, 2007
    Publication date: June 12, 2008
    Applicant: Respiratory Management Technology
    Inventors: Tal Gottesman, Bernard J. Mcgee, Vikram A. Bose-Mullick
  • Publication number: 20080015456
    Abstract: An apparatus for measuring lung ventilation, comprising: a pressure device to measure volume of air flow; an aerosol-generating device that provides aerosol particles to be released at a determined point in a breathing cycle; a mouthpiece with a detector that measures the concentration of aerosol particles for a given volume during the breathing cycle; and a computing device configured to provide lung ventilation data as a function of time constants.
    Type: Application
    Filed: June 29, 2007
    Publication date: January 17, 2008
    Applicant: Respiratory Management Technology
    Inventors: Michael McCawley, Gary Ganser, Ian Christie, Tal Gottesman, James Dalton
  • Patent number: 7241269
    Abstract: An apparatus for measuring lung ventilation, comprising: a pressure device to measure volume of air flow; an aerosol-generating device that provides aerosol particles to be released at a determined point in a breathing cycle; a mouthpiece with a detector that measures the concentration of aerosol particles for a given volume during the breathing cycle; and a computing device configured to provide lung ventilation data as a function of time constants.
    Type: Grant
    Filed: September 2, 2003
    Date of Patent: July 10, 2007
    Assignee: Respiratory Management Technology
    Inventors: Michael McCawley, Gary Ganser, Ian Christie, Tal Gottesman, James Dalton